Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)
Launched by UNIVERSITY OF ALBERTA · Oct 2, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called PARTE, is studying two different surgical techniques for people with wrist arthritis caused by previous injuries. Specifically, it focuses on patients who have a condition known as scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC). Participants will be randomly placed in one of two groups: one group will have a type of wrist fusion surgery that does not involve removing a bone called the triquetrum, while the other group will have a similar surgery that includes removing this bone. The goal is to find out which surgery leads to better results for patients.
To be eligible for this trial, participants should be between the ages of 18 and 85 and have been diagnosed with stage II or III SLAC or SNAC. They should be candidates for the surgical procedures being studied. However, individuals with other types of wrist arthritis, significant issues in their hand joints, or those who have had major wrist surgeries before are not eligible. Participants can expect to receive standard care and will be monitored for their recovery and outcomes after surgery. This study aims to help doctors choose the best surgical method for treating wrist arthritis after injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant has a stage II or III scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC) wrist and is a surgical candidate for the included surgical interventions
- Exclusion Criteria:
- • Participant has been diagnosed with other forms of wrist arthritis other than SLAC or SNAC
- • Participant has significant arthritis of the ipsilateral hand/finger joint(s), major joint trauma, previous major wrist surgery, infection or neuromuscular pathology affecting the function of the ipsilateral upper extremity or ability to make a fist
- • Participant has a physical or mental health condition preventing completion of consent or questionnaires
- • Participant does not speak/read/understand English
- • Participant has no fixed address or means of contact
- • Participant is unwilling to complete necessary follow-ups
- • Surgeon concludes that eligible salvage techniques are not appropriate at the time of surgery (based on injury characteristics or concomitant wrist pathology)
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Calgary, Alberta, Canada
London, Ontario, Canada
Ottawa, Ontario, Canada
Calgary, Alberta, Canada
St. Albert, Alberta, Canada
St. Albert, Alberta, Canada
Vancouver, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials